Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome

Published:2023-09 Issue: Volume:15 Page:100510
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Verma Subodh,Kosmopoulos Andrew,Bhatt Deepak L.,Fitchett David,Ofstad Anne Pernille,Wanner Christoph,Mattheus Michaela,Zinman Bernard,Lawler Patrick R.,Leiter Lawrence A.

Funder

Boehringer Ingelheim International GmbH

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Complications of diabetes 2017;Papatheodorou;J Diabetes Res,2018

2. Regulation of plasma triglycerides in insulin resistance and diabetes;Ginsberg;Arch Med Res,2005

3. Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol;Nichols;Diabetes Obes Metab,2019

4. Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: a review of key findings from REDUCE-IT;Gaba;J Clin Lipidol,2022

5. Substantial cardiovascular benefit from icosapent ethyl in patients with diabetes: REDUCE-IT DIABETES;Bhatt;Diabetologia,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention;Frontiers in Cardiovascular Medicine;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP